Multinational review demonstrates blood safety under gender-neutral donor selection policies, suggesting individual risk assessment effectively replaces blanket deferrals.
The experience with gender-neutral donor selection has been largely positive among the countries covered herein and seems to be acceptable to stakeholders, donors and staff. The post-implementation surveillance data collected so far appear reassuring with regards to safety, although longer observation periods are necessary. The putative risks associated with HIV antiretrovirals should be further investigated.
No takes yet. Share an insight, caveat, or question.
Lewin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: